![Travis Helm](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Travis Helm
Directeur des opérations chez Tremeau Pharmaceuticals, Inc.
Postes actifs de Travis Helm
Sociétés | Poste | Début | Fin |
---|---|---|---|
Tremeau Pharmaceuticals, Inc.
![]() Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA. | Directeur des opérations | 01/01/2019 | - |
Conseiller Juridique Général | 01/01/2019 | - |
Historique de carrière de Travis Helm
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Chief Operating Officer | 1 |
General Counsel | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Tremeau Pharmaceuticals, Inc.
![]() Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA. | Health Technology |
- Bourse
- Insiders
- Travis Helm
- Expérience